Correlation Between Tarsus Pharmaceuticals and Griffon

Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Griffon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Griffon into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tarsus Pharmaceuticals and Griffon, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Griffon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Griffon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Griffon.

Diversification Opportunities for Tarsus Pharmaceuticals and Griffon

0.55

Correlation Coefficient

Tarsus Pharmaceuticals  Griffon

Very weak diversification

The 3 months correlation between Tarsus and Griffon is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Griffon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Griffon and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Griffon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Griffon has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Griffon go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Griffon

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 1.19 times more return on investment than Griffon. However, Tarsus Pharmaceuticals is 1.19 times more volatile than Griffon. It trades about 0.32 of its potential returns per unit of risk. Griffon is currently generating about 0.17 per unit of risk. If you would invest  2,617  in Tarsus Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of  2,467  from holding Tarsus Pharmaceuticals or generate 94.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Tarsus Pharmaceuticals  vs.  Griffon

Tarsus Pharmaceuticals

Risk-Adjusted Performance

25 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Griffon

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Griffon are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, Griffon reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Tarsus Pharmaceuticals and Griffon

The main advantage of trading using opposite Tarsus Pharmaceuticals and Griffon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Griffon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Griffon will offset losses from the drop in Griffon's long position.

The idea behind Tarsus Pharmaceuticals and Griffon pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.